Mobile Phlebotomy Services Global Market Report 2025

The mobile phlebotomy services market size has grown rapidly in recent years. It will grow from $1.56 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. Growth in the historic period can be attributed to increasing demand for at-home blood collection, a rising burden of chronic illnesses requiring routine testing, growing need for convenient diagnostic services, a surge in elderly populations needing mobility-friendly care, expanded utilization of home-based healthcare, and increasing reliance on routine wellness screenings.

The mobile phlebotomy services market size is expected to see rapid growth in the next few years. It will grow to $2.68 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. Growth in the forecast period can be attributed to rising preference for doorstep medical services, increasing incidence of lifestyle-related disorders requiring regular monitoring, growing emphasis on patient-centric care delivery, a rapidly aging population across major regions, expansion of community-based preventive health programs, and increasing demand for flexible diagnostic service models. Major trends expected in the forecast period include technological advancements in digital scheduling and service automation, progress in remote sample tracking and verification technologies, innovations in handheld diagnostic and collection tools, developments in integrated patient management platforms, research and development in minimally invasive blood collection methods, and advancements in real-time logistics and routing systems.

The increasing focus on preventive healthcare and early diagnosis is expected to drive the growth of the mobile phlebotomy services market. Preventive healthcare and early diagnosis involve proactive screenings, tests, and clinical assessments designed to detect diseases early and reduce long-term health risks. This trend is being driven by growing government and health-system investments in national screening and early-detection programs, which encourage routine testing across populations. Mobile phlebotomy services play a crucial role in enhancing preventive healthcare by making blood testing more accessible and convenient, thereby increasing participation in screenings and enabling earlier detection of health issues. For example, in October 2025, the Australian Institute of Health and Welfare (AIHW) reported that over 1.9 million Australians aged 50-74 were screened through Breast Screen Australia in 2023-2024, representing 52% of the target population. The rising emphasis on preventive healthcare and early diagnosis is fueling the growth of mobile phlebotomy services.

Key companies in the mobile phlebotomy services market are adopting mobile-enabled phlebotomy scheduling and logistics platforms to improve patient access, operational efficiency, and care quality. These digital systems allow users to book in-home specimen collection visits, track phlebotomist arrivals, manage specimen transport, and integrate with laboratory workflows, enabling real-time appointment booking, route optimization, and continuous specimen monitoring. For instance, in November 2023, Quest Diagnostics launched Quest Mobile, a service offering in-home specimen collection across 44 states. The platform features online scheduling, deployment of trained mobile phlebotomists, and direct specimen transport to Quest’s laboratory network, enhancing convenience and minimizing patient travel, while ensuring more timely and reliable specimen collection.

In February 2025, DocGo, Inc., a U.S.-based provider of mobile health services, acquired PTI Health, a company specializing in mobile lab collection and phlebotomy services. This acquisition allows DocGo to expand its diagnostic capabilities by gaining access to PTI Health’s established mobile phlebotomy network, integrations with major national laboratories, and a strong service footprint in the Mid-Atlantic region. The acquisition enhances DocGo’s operational reach and service availability, further strengthening its position in the mobile phlebotomy services market.

Major companies operating in the mobile phlebotomy services market are Quest Diagnostics, NeoGenomics Laboratories Inc., Accu Reference Medical Lab, Sprinter Health, Getlabs, Phlebotek Solutions Corporation, PhlebX, myOnsite Healthcare LLC, Madison Core Labs, VeniExpress Inc., TravaLab LLC, Sunrise Pathology Services, Brio Clinical, Evexia Holdings Inc., Flebo.in, Medifyhome Health Solutions Private Limited, OptiVena, Caresticks Mobile Phlebotomy LLC, Concierge Phlebotomy LLC, Angel On Wheels Mobile Phlebotomy

North America was the largest region in the mobile phlebotomy services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mobile phlebotomy services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the mobile phlebotomy services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The mobile phlebotomy services market research report is one of a series of new reports that provides mobile phlebotomy services market statistics, including the mobile phlebotomy services industry global market size, regional shares, competitors with the mobile phlebotomy services market share, detailed mobile phlebotomy services market segments, market trends, and opportunities, and any further data you may need to thrive in the mobile phlebotomy services industry. This mobile phlebotomy services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Mobile phlebotomy services refer to blood-collection procedures performed by trained phlebotomists at a patient’s home, workplace, or another preferred location. These services include transporting all necessary equipment, safely collecting and labeling specimens, and securely transferring samples to accredited laboratories outside traditional clinical environments.

The primary service types of mobile phlebotomy services include routine blood draws, specialty blood draws, pediatric blood draws, geriatric blood draws, and others. Routine blood draws are standard laboratory collections carried out to evaluate general health, monitor ongoing medical conditions, or support regular checkups. Key applications include diagnostic testing, health screening, therapeutic drug monitoring, and other clinical evaluations. These services are used across various settings such as home care environments, assisted living facilities, nursing homes, corporate or workplace locations, and others.

The mobile phlebotomy services market includes revenues earned by entities by providing services such as sample pickup and transport, mobile specimen processing, on-site diagnostic support, patient identification and verification, specimen labelling and documentation, and post-collection coordination with laboratories. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.